| 9EH Stock | | | EUR 12.10 0.10 0.82% |
Executive
Mr. John Johnson is appointed as Chief Financial Officer of the Company, effective July 1, 2019. He has served as the Chief Financial Officer of New Century Health, a subsidiary of the Company, since March 2019. Mr. Johnson also served as the Senior Vice President of Corporationrationrate Performance of the Company from January 2018 until March 2019 and as the Vice President of Corporationrationrate Performance from April 2016 until December 2017. Mr. Johnson was instrumental in driving the Companys financial strategy and performance. Prior to joining the Company, Mr. Johnson was the Managing Partner at Riverbend Analytics, LLC from December 2015 until April 2016 and the Vice President of Strategy at PSA Healthcare from February 2013 until November 2015. since 2019.
| Age | 39 |
| Tenure | 6 years |
| Phone | 571 389 6000 |
| Web | https://www.evolenthealth.com |
Evolent Health Management Efficiency
Evolent Health's management efficiency ratios could be used to measure how well Evolent Health manages its routine affairs as well as how well it operates its assets and liabilities.
Evolent Health has accumulated 215.68
M in total debt with debt to equity ratio
(D/E) of 24.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Evolent Health has a current ratio of 1.92, which is within standard range for the sector. Debt can assist Evolent Health until it has trouble settling it off, either with new capital or with free cash flow. So, Evolent Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Evolent Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Evolent to invest in growth at high rates of return. When we think about Evolent Health's use of debt, we should always consider it together with cash and equity.
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. EVOLENT HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3800 people. Evolent Health (9EH) is traded on Frankfurt Exchange in Germany and employs 4,000 people.
Management Performance
Evolent Health Leadership Team
Elected by the shareholders, the Evolent Health's board of directors comprises two types of representatives: Evolent Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Evolent. The board's role is to monitor Evolent Health's management team and ensure that shareholders' interests are well served. Evolent Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Evolent Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan JD, Gen Officer | |
| Aammaad Shams, Chief Controller | |
| Jessica Somers, Sr Devel | |
| Seth Frank, VP Relations | |
| MAAA FSA, Chief Officer | |
| John Johnson, Chief Officer | |
| Seth Blackley, CEO CoFounder | |
| Frank Williams, CoFounder Chairman | |
| Kali Beyah, Chief Officer | |
| Dan McCarthy, CEO Pres | |
Evolent Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Evolent Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Evolent Stock
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock: Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more detail on how to invest in Evolent Stock please use our
How to Invest in Evolent Health guide.
You can also try the
ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.